Premium
Letter: should HCV cirrhotics with high bilirubin or Gilbert's syndrome be excluded from paritaprevir, ombitasvir, or dasabuvir?
Author(s) -
Madonia S.,
Orlando E.,
Stagno B.,
Cannizzaro M.,
Madonia G.,
Cottone M.
Publication year - 2016
Publication title -
alimentary pharmacology and therapeutics
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.308
H-Index - 177
eISSN - 1365-2036
pISSN - 0269-2813
DOI - 10.1111/apt.13574
Subject(s) - paritaprevir , ombitasvir , ritonavir , dasabuvir , medicine , gastroenterology , ribavirin , regimen , liver function , virology , hepatitis c virus , viral load , virus , antiretroviral therapy , human immunodeficiency virus (hiv)